STATEGICS, INC.
Biotech
Small molecule activators of the EPOR/CSF2RB tissue-protective cytokine receptor for treating neuromuscular diseases
- Grants
- $2.3M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 2 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR | $242,013 | |
| Federal grant | Department of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators | $722,532 | |
| Federal grant | Department of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators | $738,401 | |
| Federal grant | Department of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators | $515,113 | |
| Federal grant | Department of Health and Human Services · Phase II · Homogeneous Screening Assay for Cytokine Receptor Modulators | $86,761 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2559 | Resilience Therapeutics, Inc. | — | $1.4M |
| 2560 | MARKER GENE TECHNOLOGIES INC | — | — |
| 2561 | Mountain Valley MD Holdings Inc. | — | $1.4M |
| 2562 | STATEGICS, INC. | — | — |
| 2563 | Sentia Medical Sciences, Inc. | — | — |
| 2564 | Island Pharmaceuticals Ltd | — | $1.2M |
| 2565 | LactaLogics, Inc. | — | $1.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Substituted Triazolo-pyrimidine Compounds For Modulating Cell Proliferation, Differentiation And Survivalgranted
- Substituted Triazolo-pyrimidine Compounds For Modulating Cell Proliferation, Differentiation And Survivalgranted
- Substituted Triazolo-pyrimidine Compounds For Modulating Cell Proliferation, Differentiation And Survivalapplication
- Thrombopoietin Mimeticsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.